Ernexa Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $22.3M
Liabilities Breakdown FY2014
Total Liabilities: $11.3M
Asset Breakdown
Total Assets: $22.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.2M | 32.3% |
| Accounts Receivable | $2.2M | 9.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.4M | 15.3% |
| Goodwill | $1.1M | 4.9% |
| Intangible Assets | $129.0K | 0.6% |
| Other Assets | $8.3M | 37.2% |
Liabilities Breakdown
Total Liabilities: $11.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $617.0K | 5.4% |
| Long-Term Debt | $5.3M | 46.9% |
| Other Liabilities | $5.4M | 47.7% |